{"id":12950,"date":"2022-10-25T00:13:00","date_gmt":"2022-10-25T00:13:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/3913449_AE13449_0"},"modified":"2022-10-25T00:13:00","modified_gmt":"2022-10-25T00:13:00","slug":"viraleze-nasal-spray-to-be-distributed-in-hong-kong-and-macau","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=12950","title":{"rendered":"VIRALEZE Nasal Spray to be distributed in Hong Kong and Macau"},"content":{"rendered":"<div><img decoding=\"async\" src=\"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png\" class=\"ff-og-image-inserted\"><\/div>\n<p><span class=\"xn-location\">MELBOURNE, Australia<\/span>, <span class=\"xn-chron\">Oct. 25, 2022<\/span> \/PRNewswire\/ &#8212; An antiviral barrier nasal spray called VIRALEZE\u2122 will launch in <span class=\"xn-location\">Hong Kong<\/span> and <span class=\"xn-location\">Macau<\/span> in the coming weeks, following a recent sales and distribution agreement between the product&#8217;s developer Starpharma and Hengan Pharmacare Company Limited, a subsidiary of Hengan International Group Company Limited.<\/p>\n<p>Developed by Australian biotechnology company Starpharma, VIRALEZE\u2122 is a broad-spectrum nasal spray intended to provide a moisturising and protective barrier in the nose that traps and blocks cold\/respiratory viruses, including influenza, respiratory syncytial virus, and other respiratory viruses.<\/p>\n<p>VIRALEZE\u2122 will be available to more than 8 million people across <span class=\"xn-location\">Hong Kong<\/span> and <span class=\"xn-location\">Macau<\/span> through Hengan Group&#8217;s extensive distribution network of retail stores and other channels, including via leading pharmacy chains. This innovative product has already launched in pharmacies and online across the UK, <span class=\"xn-location\">Europe<\/span>, and <span class=\"xn-location\">Vietnam<\/span>, with <span class=\"xn-location\">Hong Kong<\/span> and <span class=\"xn-location\">Macau<\/span> to follow soon.<\/p>\n<p>Hengan Pharmacare Company Limited Managing Director Ms. <span class=\"xn-person\">Wong Pui Wai<\/span>, Nancy commented, &#8220;VIRALEZE\u2122 is an ideal product to add to Hengan Group&#8217;s range, which aims to provide added peace of mind in the post-pandemic world.&#8221;<\/p>\n<p><b>VIRALEZE\u2122 Nasal Spray<\/b><\/p>\n<p>VIRALEZE\u2122 is a broad-spectrum nasal spray intended to provide a moisturising and protective barrier in the nose that traps and blocks cold\/respiratory viruses. VIRALEZE\u2122 contains SPL7013, which has been shown in multiple laboratory studies to trap and block a broad spectrum of cold\/respiratory viruses, helping to prevent their adhesion, multiplication and spread.<\/p>\n<p><b>Starpharma<\/b><\/p>\n<p>Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for respiratory viruses, DEP<sup>\u00ae<\/sup> drug delivery and VivaGel<sup>\u00ae<\/sup>.<\/p>\n<p>Starpharma&#8217;s proprietary drug delivery platform technology, DEP<sup>\u00ae<\/sup>, is being used to improve pharmaceuticals, to reduce toxicities and enhance their performance. There are numerous internal and partnered programs underway to develop DEP<sup>\u00ae<\/sup> versions of existing drugs, particularly in the area of anti-cancer therapies. DEP<sup>\u00ae<\/sup> partnerships include oncology programs with AstraZeneca, with MSD in the area of Antibody Drug Conjugates (ADCs), with <span class=\"xn-person\">Chase Sun<\/span> in the area of anti-infectives and other world leading pharmaceutical companies. Partnered DEP<sup>\u00ae<\/sup> programs have the potential to generate significant future milestones and royalties.<\/p>\n<p>Starpharma has developed a number of products including VIRALEZE\u2122 nasal spray, VivaGel<sup>\u00ae<\/sup> BV, and VivaGel<sup>\u00ae<\/sup> condom.<\/p>\n<p>For more information, visit <a href=\"http:\/\/www.starpharma.com\/\" target=\"_blank\" rel=\"nofollow noopener\">www.starpharma.com<\/a>.<\/p>\n<p><b>Media<br \/><\/b><a href=\"mailto:grant@sumitmedia.com.au\" target=\"_blank\" rel=\"nofollow noopener\">grant@sumitmedia.com.au<\/a><\/p>\n<p><b>Business Development<br \/><\/b><a href=\"mailto:Bus.dev@starpharma.com\" target=\"_blank\" rel=\"nofollow noopener\">Bus.dev@starpharma.com<\/a><\/p>\n<p><b>Investor Relations<br \/><\/b><a href=\"mailto:Investor.relations@starpharma.com\" target=\"_blank\" rel=\"nofollow noopener\">Investor.relations@starpharma.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>MELBOURNE, Australia, Oct. 25, 2022 \/PRNewswire\/ &#8212; An antiviral barrier nasal spray called VIRALEZE\u2122 will launch in Hong Kong and Macau in the coming weeks, following a recent sales and distribution agreement between the product&#8217;s developer Starpharma and Hengan Pharmacare Company Limited, a subsidiary of Hengan International Group Company Limited. Developed by Australian biotechnology company [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-12950","post","type-post","status-publish","format-standard","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>VIRALEZE Nasal Spray to be distributed in Hong Kong and Macau - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=12950\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VIRALEZE Nasal Spray to be distributed in Hong Kong and Macau - My Blog\" \/>\n<meta property=\"og:description\" content=\"MELBOURNE, Australia, Oct. 25, 2022 \/PRNewswire\/ &#8212; An antiviral barrier nasal spray called VIRALEZE\u2122 will launch in Hong Kong and Macau in the coming weeks, following a recent sales and distribution agreement between the product&#8217;s developer Starpharma and Hengan Pharmacare Company Limited, a subsidiary of Hengan International Group Company Limited. Developed by Australian biotechnology company [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=12950\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-25T00:13:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12950#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12950\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"VIRALEZE Nasal Spray to be distributed in Hong Kong and Macau\",\"datePublished\":\"2022-10-25T00:13:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12950\"},\"wordCount\":413,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12950#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/en.prnasia.com\\\/prnasia.com-PC\\\/images\\\/logo-en-blue-in.png\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12950\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12950\",\"name\":\"VIRALEZE Nasal Spray to be distributed in Hong Kong and Macau - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12950#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12950#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/en.prnasia.com\\\/prnasia.com-PC\\\/images\\\/logo-en-blue-in.png\",\"datePublished\":\"2022-10-25T00:13:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12950#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12950\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12950#primaryimage\",\"url\":\"https:\\\/\\\/en.prnasia.com\\\/prnasia.com-PC\\\/images\\\/logo-en-blue-in.png\",\"contentUrl\":\"https:\\\/\\\/en.prnasia.com\\\/prnasia.com-PC\\\/images\\\/logo-en-blue-in.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12950#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VIRALEZE Nasal Spray to be distributed in Hong Kong and Macau\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VIRALEZE Nasal Spray to be distributed in Hong Kong and Macau - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=12950","og_locale":"en_US","og_type":"article","og_title":"VIRALEZE Nasal Spray to be distributed in Hong Kong and Macau - My Blog","og_description":"MELBOURNE, Australia, Oct. 25, 2022 \/PRNewswire\/ &#8212; An antiviral barrier nasal spray called VIRALEZE\u2122 will launch in Hong Kong and Macau in the coming weeks, following a recent sales and distribution agreement between the product&#8217;s developer Starpharma and Hengan Pharmacare Company Limited, a subsidiary of Hengan International Group Company Limited. Developed by Australian biotechnology company [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=12950","og_site_name":"My Blog","article_published_time":"2022-10-25T00:13:00+00:00","og_image":[{"url":"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png","type":"","width":"","height":""}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=12950#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=12950"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"VIRALEZE Nasal Spray to be distributed in Hong Kong and Macau","datePublished":"2022-10-25T00:13:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=12950"},"wordCount":413,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=12950#primaryimage"},"thumbnailUrl":"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=12950","url":"https:\/\/transmediavictoria.net.au\/?p=12950","name":"VIRALEZE Nasal Spray to be distributed in Hong Kong and Macau - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=12950#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=12950#primaryimage"},"thumbnailUrl":"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png","datePublished":"2022-10-25T00:13:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=12950#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=12950"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=12950#primaryimage","url":"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png","contentUrl":"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png"},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=12950#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"VIRALEZE Nasal Spray to be distributed in Hong Kong and Macau"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/12950","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=12950"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/12950\/revisions"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=12950"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=12950"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=12950"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}